Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction
NCT ID: NCT04446897
Last Updated: 2021-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
10 participants
INTERVENTIONAL
2020-08-03
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients
NCT05924373
Gingiva Mesenchymal Stem Cells Treatment of Chronic Periodontitis
NCT03137979
1% Metformin in Moderate and Severe Periodontitis
NCT02274090
Clinical Trials of Regeneration for Periodontal Tissue
NCT00221130
Osteoclast Impairment in Chronic Periodontitis by Regenerative Materials.
NCT03227367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mesenchymal stem cells
standard treatment according to clinical protocols plus mesenchymal stem cells
mesenchymal stem cells
autologous mesenchymal stem cells
standard treatment
standard treatment according to clinical protocols
standard treatment
standard treatment according to clinical protocols
standard treatment
standard treatment according to clinical protocols
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mesenchymal stem cells
autologous mesenchymal stem cells
standard treatment
standard treatment according to clinical protocols
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* breast-feeding
* acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis
* mental disorders
70 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Belarusian Medical Academy of Post-Graduate Education
OTHER
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Igor Volotovski, Prof
Role: STUDY_DIRECTOR
Head of the Lab of Institute of Biophysics and Cell Engineering
Sergey Rubnikovich, Prof
Role: STUDY_DIRECTOR
Head of the Department of Prosthodontics of BMAPE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Minsk, , Belarus
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IBCE_MSC(periodontitis)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.